合計 50 件の最近のインサイダー取引記録が記録されています Rubius Therapeutics, Inc. (RUBY), 内訳は 32 件の買い および 15 件の売り. インサイダー買い総額は $7.01M インサイダー売り総額は $2.46M.
最近活動のある主要インサイダーには Appelhans Dannielle, Cagnoni Pablo J, Turka Laurence A.. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — RUBY
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2023-02-24 |
Appelhans Dannielle |
CEO and President |
情報に基づく売り |
10,385 |
$0.13 |
$1.32K |
- |
| 2023-02-01 |
Cagnoni Pablo J |
Director |
情報に基づく売り |
8,448 |
$0.25 |
$2.11K |
66,082 |
| 2023-02-01 |
Appelhans Dannielle |
CEO and President |
情報に基づく売り |
3,878 |
$0.25 |
$969.50 |
10,385 |
| 2023-01-31 |
Cagnoni Pablo J |
Director |
情報に基づく売り |
7,240 |
$0.24 |
$1.74K |
74,530 |
| 2023-01-31 |
Turka Laurence A. |
Chief Scientific Officer |
情報に基づく売り |
2,593 |
$0.24 |
$622.32 |
18,391 |
| 2023-01-31 |
Appelhans Dannielle |
CEO and President |
オプション行使 |
7,500 |
- |
- |
14,263 |
| 2023-01-29 |
Cagnoni Pablo J |
Director |
オプション行使(売却) |
21,250 |
- |
- |
42,500 |
| 2023-01-29 |
Turka Laurence A. |
Chief Scientific Officer |
オプション行使 |
7,438 |
- |
- |
12,359 |
| 2022-08-09 |
Appelhans Dannielle |
Chief Operating Officer |
情報に基づく売り |
5,737 |
$0.80 |
$4.59K |
6,763 |
| 2022-07-29 |
Schaffert Susanne |
Director |
RSU 付与(制限付株式) |
50,000 |
- |
- |
50,000 |
| 2022-07-12 |
Schaffert Susanne |
Director |
不明 |
- |
- |
- |
- |
| 2022-05-12 |
Afeyan Noubar |
10 Percent Owner |
RSU 付与(制限付株式) |
25,000 |
$1.24 |
$31K |
25,000 |
| 2022-05-12 |
Epstein David R |
Director |
RSU 付与(制限付株式) |
499,762 |
- |
- |
499,762 |
| 2022-05-12 |
Rosenblatt Michael |
Director |
RSU 付与(制限付株式) |
25,000 |
$1.24 |
$31K |
25,000 |
| 2022-05-12 |
Cuss Francis M |
Director |
RSU 付与(制限付株式) |
25,000 |
$1.24 |
$31K |
25,000 |
| 2022-05-12 |
Sohn Catherine A. |
Director |
RSU 付与(制限付株式) |
25,000 |
$1.24 |
$31K |
25,000 |
| 2022-05-12 |
Holles Natalie C. |
Director |
RSU 付与(制限付株式) |
25,000 |
$1.24 |
$31K |
25,000 |
| 2022-05-12 |
Symonds Jonathan |
Director |
RSU 付与(制限付株式) |
25,000 |
$1.24 |
$31K |
25,000 |
| 2022-05-12 |
Prener Anne |
Director |
RSU 付与(制限付株式) |
25,000 |
$1.24 |
$31K |
25,000 |
| 2022-04-21 |
Epstein David R |
Director |
情報に基づく買い |
30,000 |
$1.44 |
$43.33K |
4,720,012 |
| 2022-02-01 |
Cagnoni Pablo J |
CEO and President |
情報に基づく売り |
6,730 |
$6.57 |
$44.24K |
35,520 |
| 2022-02-01 |
Keson-brookes Maiken |
CLO & Corp. Secretary |
情報に基づく売り |
2,732 |
$6.57 |
$17.96K |
5,343 |
| 2022-02-01 |
Turka Laurence A. |
Chief Scientific Officer |
情報に基づく売り |
2,517 |
$6.57 |
$16.54K |
4,921 |
| 2022-01-31 |
Cagnoni Pablo J |
CEO and President |
RSU 付与(制限付株式) |
100,000 |
- |
- |
100,000 |
| 2022-01-31 |
Carmona Jose |
Chief Financial Officer |
RSU 付与(制限付株式) |
34,500 |
- |
- |
34,500 |
| 2022-01-31 |
Keson-brookes Maiken |
CLO & Corp. Secretary |
RSU 付与(制限付株式) |
34,500 |
- |
- |
34,500 |
| 2022-01-31 |
Turka Laurence A. |
Chief Scientific Officer |
RSU 付与(制限付株式) |
34,500 |
- |
- |
34,500 |
| 2022-01-31 |
Appelhans Dannielle |
Chief Operating Officer |
RSU 付与(制限付株式) |
30,000 |
- |
- |
30,000 |
| 2022-01-29 |
Cagnoni Pablo J |
CEO and President |
オプション行使 |
21,250 |
- |
- |
42,250 |
| 2022-01-29 |
Keson-brookes Maiken |
CLO & Corp. Secretary |
オプション行使 |
8,075 |
- |
- |
8,075 |
| 2022-01-29 |
Turka Laurence A. |
Chief Scientific Officer |
オプション行使 |
7,438 |
- |
- |
7,438 |
| 2021-12-31 |
Cagnoni Pablo J |
CEO and President |
不明 |
- |
- |
- |
- |
| 2021-08-31 |
Appelhans Dannielle |
Chief Operating Officer |
RSU 付与(制限付株式) |
50,000 |
- |
- |
50,000 |
| 2021-08-09 |
Appelhans Dannielle |
Officer |
不明 |
- |
- |
- |
- |
| 2021-05-12 |
Afeyan Noubar |
10 Percent Owner |
RSU 付与(制限付株式) |
25,000 |
$23.25 |
$581.25K |
25,000 |
| 2021-05-12 |
Epstein David R |
Director |
RSU 付与(制限付株式) |
27,919 |
$23.25 |
$649.12K |
27,919 |
| 2021-05-12 |
Rosenblatt Michael |
Director |
RSU 付与(制限付株式) |
25,000 |
$23.25 |
$581.25K |
25,000 |
| 2021-05-12 |
Cuss Francis M |
Director |
RSU 付与(制限付株式) |
25,000 |
$23.25 |
$581.25K |
25,000 |
| 2021-05-12 |
Sohn Catherine A. |
Director |
RSU 付与(制限付株式) |
25,000 |
$23.25 |
$581.25K |
25,000 |
| 2021-05-12 |
Holles Natalie C. |
Director |
RSU 付与(制限付株式) |
25,000 |
$23.25 |
$581.25K |
25,000 |
| 2021-05-12 |
Symonds Jonathan |
Director |
RSU 付与(制限付株式) |
25,000 |
$23.25 |
$581.25K |
25,000 |
| 2021-05-12 |
Prener Anne |
Director |
RSU 付与(制限付株式) |
25,000 |
$23.25 |
$581.25K |
25,000 |
| 2021-03-19 |
Flagship Ventures Fund Iv General Partner Llc |
10 Percent Owner |
情報に基づく買い |
70,000 |
$29.00 |
$2.03M |
2,633,703 |
| 2021-03-15 |
Keson-brookes Maiken |
CLO & Corp. Secretary |
情報に基づく売り |
25,000 |
$20.24 |
$505.97K |
- |
| 2021-02-11 |
Epstein David R |
Director |
情報に基づく売り |
26,704 |
$14.93 |
$398.56K |
4,690,012 |
| 2021-02-10 |
Epstein David R |
Director |
情報に基づく売り |
7,404 |
$14.79 |
$109.53K |
4,716,716 |
| 2021-02-09 |
Epstein David R |
Director |
情報に基づく売り |
2,100 |
$14.83 |
$31.15K |
4,724,120 |
| 2021-02-08 |
Epstein David R |
Director |
情報に基づく売り |
89,233 |
$14.88 |
$1.33M |
4,726,220 |
| 2021-01-29 |
Cagnoni Pablo J |
CEO and President |
RSU 付与(制限付株式) |
85,000 |
- |
- |
85,000 |
| 2021-01-29 |
Keson-brookes Maiken |
CLO & Corp. Secretary |
RSU 付与(制限付株式) |
32,300 |
- |
- |
32,300 |
■ 情報付き — 公開市場取引(最も重要)
■ 情報なし(買い) — 報酬・オプション行使・転換
■ 情報なし(売り) — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効